Wedekind J E, Frey P A, Rayment I
Institute for Enzyme Research, Graduate School, College of Agricultural and Life Sciences, University of Wisconsin, Madison 53705, USA.
Biochemistry. 1996 Sep 10;35(36):11560-9. doi: 10.1021/bi9612677.
Galactose-1-phosphate uridylyltransferase catalyzes the reaction of UDP-glucose with galactose 1-phosphate to form UDP-galactose and glucose 1-phosphate during normal cellular metabolism. The reaction proceeds through a double displacement mechanism characterized by the formation of a stable nucleotidylated histidine intermediate. This paper describes the preparation of the uridylyl-enzyme complex on the crystalline enzyme from Escherichia coli and its subsequent structure determination by X-ray crystallography. The refined structure has an R-factor of 19.6% (data between 65 and 1.86 A resolution) and reveals modest conformational changes at the active site compared to the inactive UMP/UDP-enzyme complex reported previously [Wedekind, J.E., Frey, P.A., & Rayment, I. (1995) Biochemistry 34, 11049-11061]. In particular, positions of the respective UMP alpha-phosphoryl groups differ by approximately 4 A. Well-defined electron density for the nucleotidylated imidazole supports the existence of a covalent bond between N epsilon 2 of the nucleophile and the alpha-phosphorus of UMP. A hydrogen bond that is conserved in both complexes between His 166 N delta 1 and the carbonyl O of His 164 serves to properly orient the nucleophile and electrostatically stabilize the positively charged imidazolium that results from nucleotidylation. Hydrogen bonds from side-chain Gln 168 to the nonbridging phosphoryl oxygens of the nucleotidyl intermediate appear crucial for the formation and reaction of the uridylyl-enzyme complex as well. The significance of the latter interaction is underscored by the fact that the predominant cause of the metabolic disease galactosemia is the mutation of the corresponding Gln (Gln 188 in humans) to Arg. A comparison to other phosphohistidyl enzymes is described, as well as a revised model for the mechanism of the uridylyltransferase.
在正常细胞代谢过程中,1-磷酸半乳糖尿苷酰转移酶催化尿苷二磷酸葡萄糖(UDP-葡萄糖)与1-磷酸半乳糖反应,生成尿苷二磷酸半乳糖(UDP-半乳糖)和1-磷酸葡萄糖。该反应通过双置换机制进行,其特征是形成稳定的核苷酸化组氨酸中间体。本文描述了来自大肠杆菌的结晶酶上尿苷酰酶复合物的制备及其随后通过X射线晶体学确定的结构。精制后的结构的R因子为19.6%(分辨率在65至1.86 Å之间的数据),与先前报道的无活性UMP/UDP-酶复合物相比,活性位点处的构象变化较小[韦德金德,J.E.,弗雷,P.A.,& 雷门特,I.(1995年)《生物化学》34,11049 - 11061]。特别是,各自UMP的α-磷酰基的位置相差约4 Å。核苷酸化咪唑的明确电子密度支持亲核试剂的Nε2与UMP的α-磷之间存在共价键。在两种复合物中,His 166的Nδ1与His 164的羰基O之间保守的氢键用于正确定向亲核试剂,并静电稳定核苷酸化产生的带正电的咪唑鎓。来自侧链Gln 168与核苷酸中间体的非桥连磷酰氧的氢键似乎对尿苷酰酶复合物的形成和反应也至关重要。代谢疾病半乳糖血症的主要病因是相应的Gln(人类中的Gln 188)突变为Arg,这一事实突出了后一种相互作用的重要性。还描述了与其他磷酸组氨酸酶的比较,以及尿苷酰转移酶机制的修订模型。